Loading...
Odyssey Group International, Inc.
ODYY•PNK
HealthcareMedical - Devices
$0.01
$-0.00(-23.08%)
Odyssey Group International, Inc. (ODYY) Stock Overview
Explore Odyssey Group International, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Revenue Growth
0.00%
Profit Growth
$-0.14
↑ 84.70%
EPS Growth
$-0.14
↑ 87.85%
Operating Margin
0.00%
↑ 368.37%
ROE
581.45%
↑ 84.70%
Dividend Yield
0.00%
Analyst Recommendations data is not available for ODYYAnalyst Recommendations details for ODYY are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
Odyssey Health, Inc., a medical company, focuses on developing medical products. It develops CardioMap, a heart monitoring and screening device; Save A Life choking rescue devices; and PRV-001 and PRV-002 neurosteroid drug compounds to treat concussions and rare brain disorders. The company was formerly known as Odyssey Group International, Inc. Odyssey Health, Inc. was founded in 2014 and is based in Las Vegas, Nevada.
CEO
Mr. Joseph Michael Redmond
Employees
4
Headquarters
2300 West Sahara Avenue, Las Vegas, NV
Founded
2021